168 related articles for article (PubMed ID: 37750986)
1. Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells.
Gao Q; Li L; Zhang QM; Sheng QS; Zhang JL; Jin LJ; Shang RY
Chin J Integr Med; 2024 Jan; 30(1):25-33. PubMed ID: 37750986
[TBL] [Abstract][Full Text] [Related]
2. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts
Zhang P; Yuan X; Yu T; Huang H; Yang C; Zhang L; Yang S; Luo X; Luo J
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649853
[TBL] [Abstract][Full Text] [Related]
3. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
4. Berbamine dihydrochloride suppresses the progression of colorectal cancer via RTKs/Akt axis.
Liu L; Liang D; Zheng Q; Zhao M; Lv R; Tang J; Chen N
J Ethnopharmacol; 2023 Mar; 303():116025. PubMed ID: 36496042
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
6. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
7. Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer.
Wang Z; Cui Q; Shi L; Zhang M; Song P; Duan D; Guo W
Recent Pat Anticancer Drug Discov; 2022; 17(3):297-311. PubMed ID: 34951580
[TBL] [Abstract][Full Text] [Related]
8. Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway.
Chen Y; Yang J; Zuo Y; Zhang C; Pu Y; Ren Q; Li X; Huang Y; Huang H; Yang H; You O; Xia X; Lu A; Shi S; Deng Y; Lu J
Pharmacol Res; 2022 Oct; 184():106415. PubMed ID: 36029932
[TBL] [Abstract][Full Text] [Related]
9. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
Liang Y; Li S
Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
Wang Y; Liu X; Liu J; Zhang T
Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
[No Abstract] [Full Text] [Related]
11. Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1.
Zhang H; Xie F; Yuan XY; Dai XT; Tian YF; Sun MM; Yu SQ; Cai JY; Sun B; Zhang WC; Shan CL
Acta Pharmacol Sin; 2024 May; 45(5):1044-1059. PubMed ID: 38326625
[TBL] [Abstract][Full Text] [Related]
12. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
[TBL] [Abstract][Full Text] [Related]
13. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
Ghanaatgar-Kasbi S; Amerizadeh F; Rahmani F; Hassanian SM; Khazaei M; Ferns GA; Avan A
IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
[TBL] [Abstract][Full Text] [Related]
14. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
[TBL] [Abstract][Full Text] [Related]
15. Thymol Isolated from
Zeng Q; Che Y; Zhang Y; Chen M; Guo Q; Zhang W
Drug Des Devel Ther; 2020; 14():2535-2547. PubMed ID: 32669835
[TBL] [Abstract][Full Text] [Related]
16. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells].
Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
Hu F; He Z; Sun C; Rong D
Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
19. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
[TBL] [Abstract][Full Text] [Related]
20. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]